Oncodesign Investors
Oncodesign develops anticancer therapies for the treatment of patients with cancer.
Investor Type:
Healthcare Company
Technology:
Advanced Longevity (R&D)
Founded Date:
1995
Industry:
Advanced and Next Generation Therapies (Various)
Employee Number:
101-250
Headquarters:
Dijon, Bourgogne, France